Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday
Portfolio Pulse from Avi Kapoor
Wall Street analysts have updated their price targets and ratings for several US-listed companies, impacting their stock prices. Unity Biotechnology, Amgen, Johnson & Johnson, Antero Resources, J.B. Hunt Transport Services, Strategic Education, Urban Outfitters, Marinus Pharmaceuticals, Visa, and The Bank of New York Mellon Corporation all saw changes in their analyst forecasts.
April 17, 2024 | 12:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Morgan Stanley upgraded Antero Resources' price target from $26 to $36 and its rating from Equal-Weight to Overweight.
The significant price target increase and upgrade to Overweight signal strong confidence in Antero Resources' future performance.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
B of A Securities raised The Bank of New York Mellon's price target from $64 to $66, with a Buy rating.
The price target increase and continued Buy rating indicate a positive outlook for The Bank of New York Mellon.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Truist Securities increased Strategic Education's price target from $110 to $125 and upgraded the rating from Hold to Buy.
The upgrade and price target increase reflect a strong positive shift in the analyst's view on Strategic Education's prospects.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Baird increased Visa's price target from $314 to $320, maintaining an Outperform rating.
The slight price target increase with an Outperform rating suggests continued confidence in Visa's growth trajectory.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
TD Cowen reduced Amgen's price target from $370 to $360, keeping a Buy rating.
The slight price target reduction with a continued Buy rating indicates a still positive but slightly tempered outlook.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Stephens & Co. cut J.B. Hunt Transport Services' price target from $210 to $192 but maintained an Overweight rating.
The price target reduction with an unchanged Overweight rating suggests a cautiously optimistic view.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
HC Wainwright & Co. cut Unity Biotechnology's price target from $10 to $8 but maintained a Buy rating.
Despite the price target cut, the maintenance of a Buy rating suggests a positive outlook, potentially limiting negative impact.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
B of A Securities decreased Johnson & Johnson's price target from $180 to $170, with a Neutral rating.
The price target cut, alongside a Neutral rating, could suggest concerns about the company's near-term prospects.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
RBC Capital drastically reduced Marinus Pharmaceuticals' price target from $24 to $3 and downgraded it to Sector Perform.
The dramatic price target reduction and downgrade indicate significant concerns about Marinus Pharmaceuticals' outlook.
CONFIDENCE 100
IMPORTANCE 90
RELEVANCE 100
NEGATIVE IMPACT
Jefferies downgraded Urban Outfitters from Hold to Underperform and lowered the price target from $42 to $32.
The downgrade to Underperform and significant price target cut suggest a bearish outlook for Urban Outfitters.
CONFIDENCE 95
IMPORTANCE 80
RELEVANCE 90